Issue Date | Title | Author(s) |
2023 | APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer’s Disease | Lysikova, E. A.; Kuzubova, E. V.; Radchenko, A. I.; Patrakhanov, E. A.; Chaprov, K. D.; Korokin, M. V.; Deykin, A. V.; Gudyrev, O. S.; Pokrovskii, M. V. |
2023 | Cyclophilin A as a Pro-Inflammatory Factor Exhibits Embryotoxic and Teratogenic Effects during Fetal Organogenesis | Kalinina, A.; Semenova, M.; Bruter, A.; Varlamova, E.; Kubekina, M. |
2018 | New personalized genetic mouse model of Lesch-Nyhan syndrome for pharmacology and gene therapy | Kalmykov., V. A.; Kusov, P. A.; Yablonskaia, M. I.; Korshunov, E. N.; Korshunova, D. S. |
2021 | Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] gene | Soldatov, V. O.; Kukharsky, M. S.; Puchenkova, O. A.; Deykin, A. V.; Pokrovskiy, M. V. |
2022 | The tissue distribution of SARS-CoV-2 in transgenic mice with inducible ubiquitous expression of hACE2 | Dolskiy, A. A.; Gudymo, A. S.; Taranov, O. S.; Soldatov, V. O.; Deykin, A. V. |
2021 | Transgenic mice Cre-dependently expressing mutant polymerase-gamma: novel test-system for pharmacological study of mitoprotective drugs | Kubekina, M. V.; Silaeva, Yu. Yu.; Bruter, A. V.; Kolesnik, I. M.; Korokin, M. V. |